Xtant Medical Holdings, Inc.
XTNT
$0.51
$0.0234.72%
| Weiss Ratings | XTNT - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D | |||
| Rating Factors | XTNT - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | XTNT - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.55 | |||
| Price History | XTNT - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 13.33% | |||
| 30-Day Total Return | -1.45% | |||
| 60-Day Total Return | 36.66% | |||
| 90-Day Total Return | -4.85% | |||
| Year to Date Total Return | 8.95% | |||
| 1-Year Total Return | -54.46% | |||
| 2-Year Total Return | -24.99% | |||
| 3-Year Total Return | -19.32% | |||
| 5-Year Total Return | -36.25% | |||
| 52-Week High % Change | -60.73% | |||
| 52-Week Low % Change | 47.13% | |||
| Price | XTNT - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.24 | |||
| 52-Week Low Price | $0.33 | |||
| 52-Week Low Price (Date) | Dec 16, 2024 | |||
| 52-Week High Price (Date) | Mar 28, 2024 | |||
| Valuation | XTNT - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 67.73M | |||
| Enterprise Value | 96.67M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.12 | |||
| Earnings Per Share Growth | 3,768.75% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.66 | |||
| Price/Book (Q) | 1.58 | |||
| Enterprise Value/Revenue (TTM) | 0.82 | |||
| Price | $0.51 | |||
| Enterprise Value/EBITDA (TTM) | -12.31 | |||
| Enterprise Value/EBIT | -8.01 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | XTNT - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 158.25M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | XTNT - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 406 388 0480 | |||
| Address | 664 Cruiser Lane Belgrade, MT 59714 | |||
| Website | www.xtantmedical.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | XTNT - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -10.29% | |||
| Profit Margin | -14.02% | |||
| Management Effectiveness | XTNT - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -8.10% | |||
| Return on Equity | -- | |||
| Income Statement | XTNT - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 117.27M | |||
| Total Revenue (TTM) | 117.27M | |||
| Revenue Per Share | $0.74 | |||
| Gross Profit (TTM) | 68.22M | |||
| EBITDA (TTM) | -7.85M | |||
| EBIT (TTM) | -12.08M | |||
| Net Income (TTM) | -16.45M | |||
| Net Income Avl. to Common (TTM) | -16.45M | |||
| Total Revenue Growth (Q YOY) | 12.11% | |||
| Earnings Growth (Q YOY) | 26.45% | |||
| EPS Diluted (TTM) | -0.12 | |||
| EPS Diluted Growth (Q YOY) | 39.58% | |||
| Balance Sheet | XTNT - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 6.20M | |||
| Cash Per Share (Q) | $0.04 | |||
| Total Current Assets (Q) | 67.12M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 42.96M | |||
| Current Ratio (Q) | 2.348 | |||
| Book Value Per Share (Q) | $0.31 | |||
| Total Assets (Q) | 93.84M | |||
| Total Current Liabilities (Q) | 28.58M | |||
| Total Debt (Q) | 35.14M | |||
| Total Liabilities (Q) | 50.87M | |||
| Total Common Equity (Q) | 42.96M | |||
| Cash Flow | XTNT - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -3.73M | |||
| Cash from Financing (TTM) | 16.07M | |||
| Net Change in Cash (TTM) | 298.00K | |||
| Levered Free Cash Flow (TTM) | -11.83M | |||
| Cash from Operations (TTM) | -11.90M | |||
